Valérie Perrot

ORCID: 0000-0002-5541-728X · 4 papers in corpus · active 2019-2021

Study types

  • article 3
  • preprint 1

Condition tags

  • endometriosis 4
  • die_deep_infiltrating 4
  • dysmenorrhea 1
  • dyspareunia 1
article 2021
Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis
Medicine ·doi:10.1097/md.0000000000026753

ABSTRACT: Triptorelin has been used after surgery in deep infiltrating endometriosis. This post-hoc analysis aimed to evaluate symptom control between patients receiving 1-3 triptorelin injections and those receiving 4-6 injections within 2…

preprint 2020
The efficacy and safety of up to 24 weeks of triptorelin therapy following conservative surgery in patients with deep infiltrating endometriosis (DIE): a multicentre, prospective, non-interventional study in China
·doi:10.22541/au.158981325.53850315

OBJECTIVE: To evaluate the efficacy and safety of up to 24 weeks of triptorelin treatment after conservative surgery for deep infiltrating endometriosis (DIE). DESIGN: Multicentre, prospective, non-interventional. SETTING: 18 tertiary hospi…

article 2019
EP1266 Assessment of effectiveness of post-operative triptorelin administration in alleviating gastrointestinal symptoms in patients with deep infiltrating endometriosis in a multicentre, non-interventional study
·doi:10.1136/ijgc-2019-esgo.1272
article 2019
EP1267 Assessment of efficacy of post-operative triptorelin in improving pain symptoms from deep infiltrating endometriosis: a 24-month multicentre, prospective, non-interventional study in highest pain intensity patient population
·doi:10.1136/ijgc-2019-esgo.1273